Evaluating exosome dressings for skin recovery after laser treatment
Clinical Observation of Exosomes in Patients After Q-switched Laser Surgery
This study is testing if a special liquid dressing with exosomes can help improve skin healing and reduce dark spots after laser treatment for skin issues like freckles.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 38 (estimated) |
| Ages | 18 Years to 60 Years |
| Sex | All |
| Sponsor | Nanjing First Hospital, Nanjing Medical University Academic / other |
| Locations | 1 site (Nanjing, Jiangsu) |
| Trial ID | NCT06279039 on ClinicalTrials.gov |
What this trial studies
This clinical observation focuses on the effects of exosome-containing liquid dressings on the recovery of patients who have undergone Nd:YAG laser treatment for seborrheic keratosis or freckles. The study employs a half-face controlled design, where one side of the face receives exosome treatment while the other side receives a matrix for comparison. The primary goal is to assess wound healing and the prevention of post-inflammatory hyperpigmentation over an 8-week follow-up period. Patients must meet specific inclusion criteria and provide informed consent to participate.
Who should consider this trial
Good fit: Ideal candidates are individuals diagnosed with seborrheic keratosis or freckles who are undergoing Nd:YAG laser treatment.
Not a fit: Patients with a history of keloids, pregnancy, or those using certain cosmetics may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could enhance skin recovery and reduce complications after laser treatments.
How similar studies have performed: While the use of exosomes in skin treatments is a growing area of interest, this specific approach has not been widely tested in similar studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * It meets the diagnostic criteria of seborrheic keratosis or freckle； * pepole are able to follow the treatment rules of the study and were followed up for 8 weeks； * informed consent Exclusion Criteria: * History of keloids ; * Pregnancy or lactation; * Any cosmetics containing growth factor-related ingredients used within 6 months prior to treatment * Patients with incomplete observation data and incomplete course of treatment were excluded
Where this trial is running
Nanjing, Jiangsu
- Jie Dai — Nanjing, Jiangsu, China (Recruiting)
Study contacts
- Principal investigator: Jie Dai — The First Affiliated Hospital with Nanjing Medical University
- Study coordinator: jie Dai
- Email: karry_dj@126.com
- Phone: 02552271117
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.